Sartorius Stedim Biotech Balance Sheet Health
Financial Health criteria checks 2/6
Sartorius Stedim Biotech has a total shareholder equity of €3.9B and total debt of €2.7B, which brings its debt-to-equity ratio to 68.4%. Its total assets and total liabilities are €8.0B and €4.1B respectively. Sartorius Stedim Biotech's EBIT is €398.9M making its interest coverage ratio 1.8. It has cash and short-term investments of €482.6M.
Key information
68.4%
Debt to equity ratio
€2.69b
Debt
| Interest coverage ratio | 1.8x |
| Cash | €482.60m |
| Equity | €3.94b |
| Total liabilities | €4.06b |
| Total assets | €8.00b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SRTO.Y's short term assets (€1.6B) exceed its short term liabilities (€757.9M).
Long Term Liabilities: SRTO.Y's short term assets (€1.6B) do not cover its long term liabilities (€3.3B).
Debt to Equity History and Analysis
Debt Level: SRTO.Y's net debt to equity ratio (56.1%) is considered high.
Reducing Debt: SRTO.Y's debt to equity ratio has increased from 7.6% to 68.4% over the past 5 years.
Debt Coverage: SRTO.Y's debt is well covered by operating cash flow (32.2%).
Interest Coverage: SRTO.Y's interest payments on its debt are not well covered by EBIT (1.8x coverage).